THE ROLE OF CLINICAL AND HORMONAL MARKERS IN PREDICTING THE COURSE OF PREMENSTRUAL SYNDROME

Article Sidebar

PDF (Uzbek (latin))
Issue: Vol. 6 No. 1 : Eurasian Journal of Medical and Natural Sciences
Section: Articles
Published:
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Main Article Content

Тошкент давлат тиббиёт университети
info@in-academy.uz

Abstract:

Premenstrual syndrome (PMS) is a common neuroendocrine disorder among women of reproductive age and significantly impairs quality of life. Identification of reliable clinical and hormonal predictors of PMS severity remains a key challenge in modern gynecology.

Keywords:

Article Details

How to Cite:

Уктамова, . Б. (2026). THE ROLE OF CLINICAL AND HORMONAL MARKERS IN PREDICTING THE COURSE OF PREMENSTRUAL SYNDROME. Eurasian Journal of Medical and Natural Sciences, 6(1), 69–76. Retrieved from https://in-academy.uz/index.php/EJMNS/article/view/71421

References:

Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2021;224(6):536–544.

Shukurov R. N. F. et al. International scientific and practical conference «Endoscopic surgery in gynecology and reproductive medicine»: International Experience and Development Perspectives. – 2024.

Ishkulovich S. F., Mirzaevna A. F. The Role of Reproductive Surgery in Diagnostics and Treatment of Combined Pathologies in Women with Infertility Caused by Benign Structural Changes of Ovaries : дис. – USA, 2019.

Direkvand-Moghadam A, Delpisheh A, Sattar K, Sayehmiri K. Epidemiology of premenstrual syndrome: a meta-analysis. J Obstet Gynaecol. 2021;41(3):367–373.

Shukurov F. Use of contraceptives in rehabilitation of reproductive function in women with infertility after endochirurgical intervention in ovarians. – 2018.

Lanza di Scalea T, Pearlstein T. Premenstrual dysphoric disorder. Psychiatr Clin North Am. 2022;45(2):213–227.

Bäckström T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J. Mood, sexuality, hormones, and the menstrual cycle. J Clin Endocrinol Metab. 2020;105(6):e2328–e2341.

Axmedjanova X. Z., Olimova K. J., Shukurov F. I. Past tuxumdon zaxirali kech reproduktiv yoshdagi ayollarda ovulyatsiyani rag ‘batlantirishda yangicha yondashuv //Jurnal Tibbiyotda yangi kun. – 2022. – Т. 11. – С. 49.

Reed SC, Levin FR, Evans SM. Changes in mood, cognitive performance and appetite across the menstrual cycle in women with and without PMDD. Horm Behav. 2020;124:104783.

Shukurov F. I. Meaning of hormonoterapy and rehabilitation of reproductive function in women with infertility caused by benign ovarian structural changes //Materials of The 6th scientific-practical Conference Part I, Tashkent. – 2017. – С. 112-113.

Cunningham J, Yonkers KA. Ovarian steroids and mood disorders across the reproductive lifespan. Curr Psychiatry Rep. 2023;25(4):173–182.

Segebladh B, Bannbers E, Moby L, Nyberg S, Bixo M, Bäckström T. Allopregnanolone levels and premenstrual symptoms. Psychoneuroendocrinology. 2021;132:105351.

Шукуров Ф. И., Аюпова Ф. М. Роль адъювантной гормональной терапии в восстановлении репродуктивной функции у женщин после эндохирургического лечения фолликулярных кист яичников //Гинекология. – 2021. – Т. 23. – №. 1. – С. 68-72.

Dubey N, Abhishek K, Sharma S. Hormonal predictors of premenstrual syndrome severity. Reprod Biol Endocrinol. 2022;20(1):112.

Bertone-Johnson ER, Whitcomb BW, Missmer SA, Karlson EW, Rich-Edwards JW. Premenstrual syndrome and subsequent risk of chronic disease. Am J Epidemiol. 2021;190(8):1456–1464.